Bristol-Meyers Squibb Acquires Amira Pharmaceuticals for $475,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b754a444-4991-4362-9dda-10b4ff3f239b&Preview=1 - Date
7/21/2011 - Company Name
Amira Pharmaceuticals - Mailing Address
9535 Waples Street San Diego, CA 92121 - Company Description
Amira Pharmaceuticals is a privately-held biopharmaceutical company, focused on leveraging the deep expertise of a team of scientists in the field of inflammatory diseases. - Website
http://www.amirapharm.com - Transaction Type
M&A - Transaction Amount
$475,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Bristol-Myers Squibb will acquire all of Amira Pharmaceuticals’ issued and outstanding shares of capital stock and stock equivalents in an all-cash transaction for a purchase price of $325 million upfront and potential additional milestone payments totaling $150 million.
